Stay updated on Finerenone in HF with LVEF ≥40% Clinical Trial
Sign up to get notified when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2F6xwbZfLs_98rBAFM7KiAcYFflnA.uncropped.jpg&w=3840&q=75)
Latest updates to the Finerenone in HF with LVEF ≥40% Clinical Trial page
- Check66 days agoNo Change Detected
- Check67 days agoNo Change Detected
- Check69 days agoNo Change Detected
- Check70 days agoNo Change Detected
- Check72 days agoNo Change Detected
- Check80 days agoChange DetectedThe change on the webpage likely indicates an update or modification related to a study evaluating the efficacy and safety of Finerenone in participants with heart failure and left ventricular ejection fraction greater than or equal to 40%.SummaryDifference94%
Stay in the know with updates to Finerenone in HF with LVEF ≥40% Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.